Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

STIMPOD NMS450 Nerve Stimulator

K-Number: K213049 · 2022-10-16

Decision Date2022-10-16
Product CodeBXN
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

STIMPOD NMS450 Nerve Stimulator is a medical device manufactured by Xavant Technology (Pty), Ltd.. It received FDA 510(k) clearance on 2022-10-16 under approval number K213049. The device is classified under product code BXN. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the STIMPOD NMS450 Nerve Stimulator?

STIMPOD NMS450 Nerve Stimulator is a medical device that received FDA 510(k) clearance on 2022-10-16. It is manufactured by Xavant Technology (Pty), Ltd.. The 510(k) number is K213049.

When was STIMPOD NMS450 Nerve Stimulator approved by the FDA?

STIMPOD NMS450 Nerve Stimulator received FDA 510(k) clearance on 2022-10-16, under approval number K213049.

What company makes STIMPOD NMS450 Nerve Stimulator?

STIMPOD NMS450 Nerve Stimulator is manufactured by Xavant Technology (Pty), Ltd..

What is the FDA product code for STIMPOD NMS450 Nerve Stimulator?

The FDA product code for STIMPOD NMS450 Nerve Stimulator is BXN.

Related Clinical Trials

Other Devices by Xavant Technology (Pty), Ltd.

Related Devices (Code: BXN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.